Helen Lee, MD
Dermatology · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Looking this up.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Lee’s office at (408) 739-6000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A176148 · Current
Licensed to practise in California · since 2022 · expires 2028-01-31 · Lewis Katz School of Medicine at Temple University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$52,017
Medicare paid this office $52,017 for 266 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 102 | $9,260 | $78 |
| New patient visit (30+ min) | 88 | $7,808 | $89 |
| Return visit (30+ min) | 43 | $6,307 | $115 |
| Destruction of skin growth, 1-14 growths | 46 | $6,024 | $114 |
| Biopsy of related skin growth, first growth | 45 | $4,409 | $88 |
See all 10 services
| Short return visit (20+ min) | 102 | $9,260 | $78 |
| New patient visit (30+ min) | 88 | $7,808 | $89 |
| Return visit (30+ min) | 43 | $6,307 | $115 |
| Destruction of skin growth, 1-14 growths | 46 | $6,024 | $114 |
| Biopsy of related skin growth, first growth | 45 | $4,409 | $88 |
| Destruction of precancer skin growth, 1 growth | 62 | $4,119 | $54 |
| New patient visit (45+ min) | 28 | $3,804 | $136 |
| Destruction of precancer skin growth, 2-14 growths | 49 | $1,701 | $7 |
| Punch biopsy, first skin growth | 11 | $1,617 | $135 |
| Application of ultraviolet light to skin | 14 | $473 | $26 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 14 | More than 69% of doctors who do this |
| Removal of skin lesions | 330 | More than 83% of doctors who do this |
| Skin biopsy | 119 | More than 78% of doctors who do this |
Who their Medicare patients are
266 Original Medicare patients in 2024. Average age 75 · Women 58% · Also on Medicaid 11% · Health risk score 0.90. At or below the middle of the specialty; the typical dermatology clinician is at 1.01.
Conditions among them: High blood pressure 54% · Diabetes 21% · Coronary heart disease 17% · Chronic kidney disease 17% · Depression 14% · Cancer 13% · Atrial fibrillation 13% · Heart failure 8% · Stroke 8% · COPD 7% · Dementia 5%.
The office billed $189,828, Medicare allowed $72,499 and paid $52,017; for 804 services of 38 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 266 | 804 | 75 | 0.90 | $189,828 | $52,017 |
| 2023 | 497 | 2,204 | 75 | 0.96 | $235,141 | $101,689 |
| 2022 | 541 | 2,094 | 74 | 0.97 | $234,742 | $91,110 |
| 2021 | 269 | 863 | 73 | 0.78 | $140,659 | $36,072 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 14 services
| Short return visit (20+ min) | 257 | $17,288 | $62 |
| Destruction of skin growth, 1-14 growths | 124 | $11,892 | $88 |
| Destruction of precancer skin growth, 1 growth | 216 | $9,091 | $39 |
| Biopsy of related skin growth, first growth | 110 | $8,479 | $72 |
| New patient visit (30+ min) | 104 | $8,303 | $80 |
| Return visit (30+ min) | 66 | $6,428 | $88 |
| Destruction of precancer skin growth, 2-14 growths | 168 | $4,929 | $6 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 15 | $3,929 | $246 |
| Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 22 | $3,407 | $122 |
| Destruction of precancer skin growth, 15 or more growths | 21 | $2,988 | $136 |
| New patient visit (45+ min) | 29 | $2,618 | $90 |
| Application of ultraviolet light to skin | 22 | $2,414 | $27 |
| Biopsy of related skin growth, each additional growth | 34 | $2,398 | $46 |
| Short return visit | 18 | $952 | $50 |
2022: 13 services
| Short return visit (20+ min) | 296 | $19,684 | $58 |
| Destruction of skin growth, 1-14 growths | 154 | $12,565 | $70 |
| Return visit (30+ min) | 111 | $9,684 | $76 |
| Destruction of precancer skin growth, 1 growth | 208 | $9,410 | $40 |
| Biopsy of related skin growth, first growth | 126 | $6,966 | $51 |
| New patient visit (30+ min) | 87 | $6,623 | $76 |
| New patient visit (45+ min) | 41 | $4,075 | $99 |
| Destruction of precancer skin growth, 2-14 growths | 156 | $3,212 | $5 |
| Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | 16 | $3,144 | $197 |
| Biopsy of related skin growth, each additional growth | 29 | $1,532 | $35 |
| Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | 12 | $1,125 | $94 |
| Short return visit | 26 | $957 | $35 |
| Injection into skin growth, 1-7 growths | 14 | $299 | $21 |
2021: 8 services
| Short return visit (20+ min) | 142 | $9,136 | $57 |
| Return visit (30+ min) | 71 | $6,430 | $85 |
| Destruction of skin growth, 1-14 growths | 80 | $5,206 | $57 |
| Destruction of precancer skin growth, 1 growth | 90 | $3,720 | $37 |
| New patient visit (30+ min) | 49 | $3,051 | $62 |
| Biopsy of related skin growth, first growth | 59 | $1,422 | $23 |
| Biopsy of related skin growth, each additional growth | 16 | $404 | $20 |
| Destruction of precancer skin growth, 2-14 growths | 63 | $373 | $2 |
Medicaid work
$39,763 in 2023
Medicaid paid $39,763 for 333 billed services this clinician did in 2023, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 112 | $13,434 |
| Return visit (30+ min) | 66 | $8,504 |
| New patient visit (45+ min) | 51 | $8,481 |
| Short return visit (20+ min) | 90 | $8,111 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 14 | $1,233 |
| 2023 | 333 | 5 | 26 | $39,763 |
| 2022 | 473 | 6 | 34 | $51,010 |
| 2021 | 175 | 3 | 31 | $16,655 |
See the largest Medicaid services in earlier years
2022
| New patient visit (45+ min) | 108 | $16,250 |
| New patient visit (30+ min) | 121 | $13,280 |
| Return visit (30+ min) | 140 | $12,431 |
| Short return visit (20+ min) | 77 | $6,636 |
| Tangential biopsy of skin (eg, shave, scoop, saucerize, curette); single lesion | 14 | $1,496 |
| Destruction (eg, laser surgery, electrosurgery, cryosurgery, chemosurgery, surgical curettement), premalignant lesions (eg, actinic keratoses); first lesion | 13 | $917 |
2021
| New patient visit (45+ min) | 64 | $8,211 |
| New patient visit (30+ min) | 82 | $6,160 |
| Return visit (30+ min) | 29 | $2,284 |
Drugs they prescribed that Part D paid
$84,309
Pharmacies billed $84,309 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 292) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
277 generic and 15 brand-name prescriptions · $84,309 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Tacrolimus | 17 | $1,870 | $110 |
| Clobetasol Propionate | 35 | $1,518 | $43 |
| Fluocinonide | 32 | $1,073 | $34 |
| Ketoconazole | 46 | $701 | $15 |
| Mometasone Furoate | 20 | $350 | $17 |
See all 7 drugs
| Tacrolimus | 17 | $1,870 | $110 |
| Clobetasol Propionate | 35 | $1,518 | $43 |
| Fluocinonide | 32 | $1,073 | $34 |
| Ketoconazole | 46 | $701 | $15 |
| Mometasone Furoate | 20 | $350 | $17 |
| Triamcinolone Acetonide | 33 | $312 | $9 |
| Finasteride | 14 | $174 | $12 |
Year by year
| 2024 | 292 | 151 | 0% (0) | 5% | $84,309 |
| 2023 | 813 | 362 | 0% (0) | 7% | $571,435 |
| 2022 | 799 | 381 | 0% (0) | 10% | $304,928 |
| 2021 | 376 | 190 | 0% (0) | 20% | $183,845 |
| 2020 | 305 | 123 | 0% (0) | 16% | $101,787 |
| 2019 | 354 | 136 | 0% (0) | 10% | $107,436 |
| 2018 | 137 | 54 | 0% (0) | 15% | $20,776 |
| 2017 | 21 | 12 | 0% (0) | None | $2,216 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 16 drugs
| Skyrizi | 23 | $476,298 | $20,709 |
| Dupixent | 14 | $51,637 | $3,688 |
| Clobetasol Propionate | 105 | $6,522 | $62 |
| Fluorouracil | 58 | $5,692 | $98 |
| Ketoconazole | 160 | $4,152 | $26 |
| Valacyclovir | 17 | $1,061 | $62 |
| Triamcinolone Acetonide | 110 | $988 | $9 |
| Doxycycline Hyclate | 25 | $969 | $39 |
| Mometasone Furoate | 45 | $875 | $19 |
| Metronidazole | 13 | $705 | $54 |
| Hydroxychloroquine Sulfate | 11 | $671 | $61 |
| Fluocinonide | 11 | $485 | $44 |
| Mupirocin | 43 | $395 | $9 |
| Hydrocortisone | 46 | $245 | $5 |
| Finasteride | 11 | $235 | $21 |
| Doxycycline Monohydrate | 16 | $192 | $12 |
2022: 19 drugs
| Dupixent | 12 | $39,281 | $3,273 |
| Clobetasol Propionate | 97 | $5,884 | $61 |
| Fluorouracil | 40 | $3,707 | $93 |
| Ketoconazole | 91 | $2,821 | $31 |
| Tacrolimus | 15 | $2,663 | $178 |
| Fluocinonide | 30 | $1,880 | $63 |
| Betamethasone Dipropionate | 31 | $1,718 | $55 |
| Metronidazole | 15 | $1,328 | $89 |
| Calcipotriene | 12 | $1,194 | $100 |
| Doxycycline Monohydrate | 28 | $901 | $32 |
| Triamcinolone Acetonide | 92 | $840 | $9 |
| Betamethasone Diprop Augmented | 18 | $783 | $43 |
| Mometasone Furoate | 31 | $664 | $21 |
| Doxycycline Hyclate | 18 | $590 | $33 |
| Valacyclovir | 16 | $467 | $29 |
| Mupirocin | 45 | $431 | $10 |
| Nystatin | 15 | $279 | $19 |
| Hydrocortisone | 50 | $240 | $5 |
| Finasteride | 16 | $234 | $15 |
2021: 10 drugs
| Dupixent | 13 | $42,698 | $3,284 |
| Clobetasol Propionate | 40 | $4,252 | $106 |
| Clindamycin Phosphate | 17 | $1,389 | $82 |
| Betamethasone Dipropionate | 19 | $1,177 | $62 |
| Ketoconazole | 43 | $1,119 | $26 |
| Fluorouracil | 12 | $1,052 | $88 |
| Doxycycline Monohydrate | 14 | $738 | $53 |
| Triamcinolone Acetonide | 44 | $400 | $9 |
| Valacyclovir | 12 | $396 | $33 |
| Hydrocortisone | 25 | $336 | $13 |
2020: 8 drugs
| Clobetasol Propionate | 53 | $7,008 | $132 |
| Metronidazole | 11 | $971 | $88 |
| Ketoconazole | 39 | $857 | $22 |
| Fluocinonide | 13 | $681 | $52 |
| Clindamycin Phosphate | 13 | $663 | $51 |
| Doxycycline Hyclate | 11 | $627 | $57 |
| Triamcinolone Acetonide | 49 | $537 | $11 |
| Hydrocortisone | 16 | $100 | $6 |
2019: 9 drugs
| Clobetasol Propionate | 49 | $5,126 | $105 |
| Fluorouracil | 11 | $2,379 | $216 |
| Ketoconazole | 48 | $1,217 | $25 |
| Fluocinonide | 17 | $956 | $56 |
| Triamcinolone Acetonide | 44 | $656 | $15 |
| Doxycycline Hyclate | 19 | $577 | $30 |
| Ammonium Lactate | 17 | $416 | $24 |
| Hydrocortisone | 37 | $321 | $9 |
| Nystatin | 11 | $78 | $7 |
2018: 1 drug
| Clobetasol Propionate | 12 | $1,224 | $102 |
Money from drug and device companies
$1,160 in 2025
| 2025 | 13 | 45 | None | $1,160 |
| 2024 | 15 | 31 | None | $922 |
| 2023 | 8 | 17 | None | $371 |
| 2022 | 8 | 18 | None | $403 |
| 2021 | 3 | 3 | None | $272 |
| 2020 | 3 | 4 | None | $210 |
| 2019 | 4 | 5 | None | $457 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genzyme | Dupixent | $277 | 4 payments
|
| Janssen Biotech | Tremfya | $141 | 5 payments
|
| Incyte | Opzelura | $136 | 8 payments
|
| Arcutis Biotherapeutics | Zoryve | $135 | 8 payments
|
| Lilly USA | Taltz | $87 | 4 payments
|
| Novartis Pharmaceuticals | Cosentyx | $66 | 3 payments
|
See all 45 published payments
| Galderma Laboratories L.P. | Meals · 2025-12-11 | Nemluvio | $18 |
| Incyte | Meals · 2025-12-02 | Opzelura | $4 |
| Incyte | Meals · 2025-12-02 | Opzelura | $17 |
| Arcutis Biotherapeutics | Meals · 2025-11-20 | Zoryve | $31 |
| Janssen Biotech | Meals · 2025-11-17 | Tremfya | $14 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Sotyktu | $32 |
| Incyte | Meals · 2025-11-04 | Opzelura | $26 |
| Galderma Laboratories L.P. | Meals · 2025-10-27 | Nemluvio | $26 |
| Incyte | Meals · 2025-10-21 | Opzelura | $29 |
| Genzyme | Meals · 2025-10-20 | Dupixent | $47 |
| Arcutis Biotherapeutics | Meals · 2025-10-16 | Zoryve | $16 |
| Novartis Pharmaceuticals | Meals · 2025-10-09 | Rhapsido | $21 |
| Ucb | Meals · 2025-09-29 | Bimzelx | $28 |
| Arcutis Biotherapeutics | Meals · 2025-09-16 | Zoryve | $19 |
| Lilly USA | Meals · 2025-08-28 | Taltz | $31 |
| Janssen Biotech | Meals · 2025-08-21 | Tremfya | $27 |
| Arcutis Biotherapeutics | Meals · 2025-08-21 | Zoryve | $2 |
| Regeneron Healthcare Solutions | Meals · 2025-08-14 | Dupixent | $38 |
| Organon | Meals · 2025-07-31 | None | $27 |
| Lilly USA | Meals · 2025-07-26 | Taltz | $17 |
| Organon | Meals · 2025-07-22 | Vtama | $26 |
| Arcutis Biotherapeutics | Meals · 2025-07-22 | Zoryve | $16 |
| Janssen Biotech | Meals · 2025-07-14 | Tremfya | $34 |
| Abbvie | Meals · 2025-07-01 | Skyrizi | $17 |
| Janssen Biotech | Meals · 2025-06-26 | Tremfya | $36 |
| Arcutis Biotherapeutics | Meals · 2025-06-16 | Zoryve | $17 |
| Genzyme | Meals · 2025-05-20 | Dupixent | $41 |
| Galderma Laboratories L.P. | Meals · 2025-05-19 | Nemluvio | $19 |
| Novartis Pharmaceuticals | Meals · 2025-05-08 | Cosentyx | $18 |
| Incyte | Meals · 2025-04-22 | Opzelura | $31 |
| Incyte | Meals · 2025-04-18 | Opzelura | $2 |
| Arcutis Biotherapeutics | Meals · 2025-04-14 | Zoryve | $18 |
| Abbvie | Meals · 2025-04-10 | Skyrizi | $22 |
| Genzyme | Meals · 2025-03-27 | Dupixent | $146 |
| Lilly USA | Meals · 2025-03-24 | Ebglyss | $22 |
| Almirall | Meals · 2025-02-11 | Klisyri | $19 |
| Incyte | Meals · 2025-02-05 | Opzelura | $2 |
| Incyte | Meals · 2025-02-05 | Opzelura | $24 |
| Genzyme | Meals · 2025-02-03 | Dupixent | $42 |
| Lilly USA | Meals · 2025-01-29 | Taltz | $17 |
| Novartis Pharmaceuticals | Meals · 2025-01-28 | Cosentyx | $27 |
| Janssen Biotech | Meals · 2025-01-17 | Tremfya | $30 |
| Ucb | Meals · 2025-01-16 | Bimzelx | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-01-13 | Sotyktu | $22 |
| Arcutis Biotherapeutics | Meals · 2025-01-10 | Zoryve | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $922
| Regeneron Healthcare Solutions | Libtayo | $190 | 3 payments
|
| Incyte | Opzelura | $105 | 4 payments
|
| Arcutis Biotherapeutics | Zoryve | $97 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $89 | 3 payments
|
| Genzyme | Dupixent | $73 | 2 payments
|
| Ucb | Bimzelx | $63 | 2 payments
|
| Novartis Pharmaceuticals | Cosentyx | $50 | 2 payments
|
| Dermavant Sciences | Vtama | $49 | 2 payments
|
| Janssen Biotech | Tremfya | $36 | 2 payments
|
| Almirall | Klisyri | $33 | 2 payments
|
| STRATA Skin Sciences | Xtrac | $30 | 1 payment
|
| LEO Pharma | Adbry | $29 | 1 payment
|
| Lilly USA | Ebglyss | $26 | 1 payment
|
| Galderma Laboratories L.P. | None | $25 | 1 payment
|
| Pfizer | Litfulo | $25 | 1 payment
|
2023: $371
| LEO Pharma | Adbry | $102 | 4 payments
|
| Pfizer | Eucrisa | $75 | 4 payments
|
| Abbvie | Rinvoq | $50 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Sotyktu | $48 | 2 payments
|
| Amgen | Otezla | $33 | 1 payment
|
| Genzyme | None | $24 | 1 payment
|
| Arcutis Biotherapeutics | None | $23 | 1 payment
|
| Incyte | Opzelura | $17 | 1 payment
|
2022: $403
| Abbvie | Rinvoq | $165 | 9 payments
|
| LEO Pharma | Adbry | $52 | 2 payments
|
| Lilly USA | Taltz | $48 | 2 payments
|
| Genzyme | Dupixent | $35 | 1 payment
|
| Amgen | Otezla | $34 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $31 | 1 payment
|
| Incyte | Opzelura | $25 | 1 payment
|
| Janssen Biotech | Remicade | $15 | 1 payment
|
2021: $272
| Genzyme | Dupixent | $117 | 1 payment
|
| Janssen Biotech | Tremfya | $90 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $65 | 1 payment
|
2020: $210
| Janssen Biotech | Tremfya | $99 | 1 payment
|
| Sanofi-Aventis U.S. | Dupixent | $72 | 1 payment
|
| Regeneron Healthcare Solutions | Libtayo | $39 | 2 payments
|
2019: $457
| Genzyme | Dupixent | $122 | 1 payment
|
| Ortho Dermatologics a division of Bausch Health US | Siliq | $119 | 1 payment
|
| Novartis Pharmaceuticals | Cosentyx | $116 | 2 payments
|
| Janssen Biotech | Tremfya | $100 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1023540796
- Licence
- CA A176148California A176148: Current · expires 2028-01-31
- Trained
- Temple University School of Medicine, 2017
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2017-03-31
- NPI last updated
- 2023-09-13
- NPI record certified
- 2023-09-13
This is when the NPI record was last certified, not a medical board exam.